Arkin Digital Health

growth-positive

Dr. Nadav Shimoni, Managing Director of Arkin Digital Health, discusses the investment outlook for 2023. He predicts a shift towards focusing on solid business elements like sustainability and scalability, rather than just top-line revenues. He identifies value and thesis-driven entrepreneurs and investors as the winners of 2022, while those who solely focused on revenue growth without considering costs are the losers. Shimoni expects more companies to raise funds in 2023, leading to a valuation reset and unfavorable terms. He believes the Israeli market will be affected by larger markets being more price-sensitive and having fewer buyers. In terms of preparation for the coming year, healthcare companies should validate their go-to-market strategies and make necessary adjustments. Layoffs in 2021 are seen as a correction to the unsustainable hiring environment. The fate of unicorns born in 2022 depends on their ability to become sustainable public companies or successful M&A targets.

growth-positive

Israeli venture capital firm Arkin Holdings is focusing on digital health and has made seven investments in the space. The firm established a digital health vertical in 2021 and has dedicated a percentage of its $2 billion fund to this area. Arkin Holdings invests in companies targeting the U.S market, whether they are Israeli or non-Israeli. The firm has recently expanded the advisory board for its digital health arm. The board includes industry experts such as Dr. David Shulkin, Dr. Deneen Vojta, Prof. Eyal Zimlichman, Darren Dworkin, and Dr. Steve Klasko. Arkin Holdings believes that digital health combines healthcare and technology and aims to provide a unique perspective in this field.

growth-positive

Arkin Holdings has closed a $270 million biotech fund to focus on crossover investments. The fund will target late growth stage pre-IPO companies and early post-IPO companies. The fund was backed by leading Israeli institutional investors including Migdal Insurance, Phoenix, Harel, More Investments, Menorah-Mivtachim, and Leumi Partners. The fund will be managed by Pini Orbach and Dr. Alon Lazarus. Orbach stated that the fund size is sufficient to make 8-10 investments and prove their capabilities, with hopes to raise a bigger fund in the future.

growth-positive

Arkin Holdings, with $1.5 billion in assets under management, is setting up an investment arm focused on digital health. The new investment arm will be led by Dr. Nadav Shimoni and will primarily invest in early-stage startups. Arkin Holdings manages its assets through various funds, including Arkin Bio Ventures and Accelmed. The companys CEO, Nir Arkin, believes that the digital health sector is experiencing significant growth and intends to be involved in every life sciences sector. The article does not mention any specific partners, customers, valuation amount, layoffs, or acquisition amount. The event described in the article does not have a specific date.

growth-positive

Arkin Holdings, which manages about $1.5 billion in its funds, is entering a new field - digital health - and setting up an investment arm in the field. The new investment arm in the group will be led by Dr. Nadav Shimoni, who recently joined the group as head of the field. The investments are expected to be made mainly in early-stage start-ups. Arkin Holdings manages, as mentioned, about $1.5 billion through the Arkin Bio Ventures 1, Arkin Bio Ventures 2, Xlmed, Sphera Global Healthcare and Sphera Biotech funds.